STLN logo
NASDAQ · STLNMedical - Care FacilitiesUpdated Nov 5, 2026

Starling Oncology, Inc. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Starling Oncology, Inc. (STLN) is 209.81%

According to Starling Oncology, Inc.’s latest financial reports and current stock price. The company's current ROE is 209.81%. This represents a change of 254.38% compared to the average of 59.20% of the last 4 quarters.

Starling Oncology, Inc. (STLN) Historical ROE (quarterly & annually)

How has STLN ROE performed in the past?

The mean historical ROE of Starling Oncology, Inc. over the last ten years is 385.53%. The current 209.81% ROE has changed -45.58% with respect to the historical average. Over the past ten years (40 quarters), STLN's ROE was at its highest in in the September 2025 quarter at 134.46%. The ROE was at its lowest in in the March 2026 quarter at 15.30%.

Quarterly (TTM)
Annual

Average

385.53%

Median

385.53%

Minimum

385.53%

Maximum

385.53%

Starling Oncology, Inc. (STLN) ROE by Quarter and Year

Discovering the peaks and valleys of Starling Oncology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 385.53%

Minimum Annual Increase = 0%

Minimum Annual ROE = 385.53%

Quarterly (TTM)
Annual
YearROEChange

Starling Oncology, Inc. (STLN) Average ROE

How has STLN ROE performed in the past?

The current ROE of Starling Oncology, Inc. (STLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

385.53%

5-year avg

385.53%

10-year avg

385.53%

Starling Oncology, Inc. (STLN) ROE vs. Peers

How is STLN’s ROE compared to its peers?

Starling Oncology, Inc.’s ROE is

CompanyROEMarket cap

Build a custom stock screener for Starling Oncology, Inc. (STLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Starling Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Starling Oncology, Inc. (STLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Starling Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Starling Oncology, Inc.'s ROE?

How is the ROE calculated for Starling Oncology, Inc. (STLN)?

What is the highest ROE for Starling Oncology, Inc. (STLN)?

What is the 3-year average ROE for Starling Oncology, Inc. (STLN)?

What is the 5-year average ROE for Starling Oncology, Inc. (STLN)?

How does the current ROE for Starling Oncology, Inc. (STLN) compare to its historical average?